Primary or Revision: How an Orthopaedic Implant Manufacturer Used Bespoke Research and Strategy Advisory to Evaluate Whether the Revision Surgery Segment Was Worth Entering

Revision orthopaedic surgery is not simply a more complex version of primary replacement. It requires a different implant design philosophy, different instrumentation, different surgical technique, and a depth of case experience that surgeons develop over years of revision-specific practice.

The client’s commercial team was right to be cautious about the competitive landscape. The three or four established revision implant systems had become the dominant choice at most high-volume revision centres precisely because they had been present long enough for surgeon training programmes to be built around them, for fellowship exposure to be concentrated in their systems, and for the clinical literature to be populated by their published outcomes.

The clinical team’s instinct about the long-term opportunity was also correct. The revision procedure volume was growing structurally as the cohort of patients who received primary implants in the nineteen-nineties reached the lifespan end of those devices.

Key Challenges

• No bespoke research establishing the competitive dynamics and surgeon relationship structure specific to the revision implant segment the client was evaluating.
• No assessment of the success history of recent new entrants into the revision implant market and which entry strategies had and had not produced commercial traction.
• A commercial team sceptical of direct entry into a segment where surgeon preference was entrenched and the clinical evidence base strongly favoured established players.
• No structured evaluation of alternative entry pathways, such as academic medical centre partnerships, that might avoid the direct competition with established revision relationships.
• A development investment requirement for revision-specific implant designs and instrumentation that needed to be justified against a realistic commercial pathway.
• Board expectation that a revision segment entry recommendation be grounded in an honest assessment of competitive barriers rather than market size alone.

Orthopaedic implant market segments where surgeon preference is built on procedural familiarity and fellowship training are fundamentally different from segments where product features or price drive switching. A new entrant that competes head-on for established revision surgeons is competing against years of accumulated experience. A new entrant that trains the next generation of revision surgeons is building the preference of the market’s future participants rather than trying to change the preferences of its current ones.